Drug intelligence / Profile preview

low-titer group o+ non-leukoreduced whole blood

Development stage
Unknown
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Intravenous
01

Overview

**Low-titer group O+ non-leukoreduced whole blood (LTOWB)** is a complete blood product collected from group O RhD-positive donors with low levels of anti-A and anti-B antibodies (typically titers <256, varying by blood center). It contains red blood cells, cold-stored platelets, and plasma in a single unit, stored cold for up to 21 days, and is non-leukocyte-reduced. Primarily indicated for rapid, balanced resuscitation in life-threatening hemorrhage, such as trauma, where oxygen-carrying capacity, coagulation factors, platelets, and volume expansion are needed urgently, especially when patient blood type is unknown. It serves as a universal donor product, simplifying logistics over separate components, reducing donor exposures, and minimizing dilutional coagulopathy risks.[1][2][3]

Other names
LTOWBlow titer group O whole bloodlow-titer O+ whole blood

Beyond the preview

Go deeper on low-titer group o+ non-leukoreduced whole blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on low-titer group o+ non-leukoreduced whole blood.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call